Protecting patient privacy in tabular synthetic health data: a regulatory perspective
- PMID: 41315669
- PMCID: PMC12663144
- DOI: 10.1038/s41746-025-02112-0
Protecting patient privacy in tabular synthetic health data: a regulatory perspective
Abstract
Synthetic tabular data generation (SDG) is increasingly important in healthcare research and innovation while preserving patients' privacy. However, ethical concerns remain, primarily over residual privacy vulnerability and insufficient oversight. This review analyzes the only published SDG regulatory guidelines to date, from United Kingdom, Singapore, and South Korea. All emphasize privacy, acknowledging synthetic data is not inherently free from disclosure risks. Thresholds for sufficiently low risk are yet to be determined.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: At the time of writing KEE had shares in Aetion, which acquired his university spin-off company that develops SDG software. KEE was also the Scholar-in-Residence at the Office of the Information and Privacy Commissioner of Ontario at the time of writing.
Figures
References
-
- Templ, M., Meindl, B., Kowarik, A. & Dupriez, O. Simulation of synthetic complex data: the r package simPop. J. Stat. Softw.79, 1–38 (2017). - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
